Aspen’s pharma growth offsets contract loss, restructuring
Aspen Pharmacare Holdings says its mixed performance reflects a transitional period, buoyed by strong commercial pharmaceuticals growth that offset a cancelled contract and costly factory restructuring.
Black News 
Aspen Pharmacare Holdings says its mixed performance reflects a transitional period, buoyed by strong commercial pharmaceuticals growth that offset a cancelled contract and costly factory restructuring.
.png)
